Ramos T
Scand J Immunol. 1983 May;17(5):411-7. doi: 10.1111/j.1365-3083.1983.tb00807.x.
The requirement for H-2-coded antigens on the cell surface of stimulator cells used for induction of B-cell responsiveness against haptenated (fluorescein isothiocyanate (FITC)) syngeneic cells was studied using H-2-less F9 teratocarcinoma cell lines. I found that FITC-labelled F9 cells, in contrast to normal spleen cells, could not induce hapten-specific antibody synthesis. The effect of treatment of stimulator cells with glutaraldehyde or trypsin before or after hapten labelling was also analysed. It was found that regardless of the order of treatment, hapten-specific antibody synthesis could not be induced by cells treated with glutaraldehyde or trypsin. In addition, hapten-specific B-cell unresponsiveness could not be induced by FITC-labelled glutaraldehyde-treated syngeneic lymphocytes. However, cold targets treated with trypsin or glutaraldehyde efficiently blocked T-cell-mediated cytotoxicity. The requirement for H-2-coded antigens for B-cell activation against haptenated syngeneic lymphocytes is discussed.
利用无H-2的F9畸胎瘤细胞系,研究了用于诱导B细胞对半抗原化(异硫氰酸荧光素(FITC))同基因细胞产生反应性的刺激细胞表面H-2编码抗原的需求。我发现,与正常脾细胞相比,FITC标记的F9细胞不能诱导半抗原特异性抗体合成。还分析了在半抗原标记之前或之后用戊二醛或胰蛋白酶处理刺激细胞的效果。结果发现,无论处理顺序如何,用戊二醛或胰蛋白酶处理的细胞都不能诱导半抗原特异性抗体合成。此外,FITC标记的经戊二醛处理的同基因淋巴细胞不能诱导半抗原特异性B细胞无反应性。然而,用胰蛋白酶或戊二醛处理的冷靶细胞能有效阻断T细胞介导的细胞毒性。讨论了B细胞激活对半抗原化同基因淋巴细胞产生反应所需的H-2编码抗原。